First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01554085
Recruitment Status : Terminated (ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical development.)
First Posted : March 14, 2012
Last Update Posted : October 31, 2017
Vertex Pharmaceuticals Incorporated
Information provided by (Responsible Party):
Alios Biopharma Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 30, 2012
  Actual Study Completion Date : September 30, 2012